Celltrion
068270.KS
#942
Rank
โ‚น2.485 T
Marketcap
โ‚น10,836
Share price
4.09%
Change (1 day)
5.43%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น165.10

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น180.10. an increase over its 2024 EPS that were of โ‚น117.09.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025โ‚น308.73163.66%
2024โ‚น117.09-53.73%
2023โ‚น253.08-2.08%
2022โ‚น258.45-11.72%
2021โ‚น292.762.03%
2020โ‚น286.9282.8%
2019โ‚น156.9618.31%
2018โ‚น132.67-36.33%
2017โ‚น208.38161.25%
2016โ‚น79.762.86%
2015โ‚น77.5517.84%
2014โ‚น65.815.87%
2013โ‚น62.15-70.85%
2012โ‚น213.23134.09%
2011โ‚น91.0943.59%
2010โ‚น63.4474.49%
2009โ‚น36.35317.8%
2008โ‚น8.70-71.7%
2007โ‚น30.75